Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply

Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply

Wave Life Sciences, Inc. is a clinical-stage biotechnology company focused on ribonucleic acid (RNA) medicines (also known as oligonucleotides), or those targeting RNA, to transform human health. The Company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and common disorders. Its toolkit of RNA-targeting modalities, including RNA interference (RNAi) (SpiNA) and RNA editing (AIMers), provides unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. The Company's pipeline is focused on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006) and PNPLA3 I148M liver disease (WVE-008) programs and also includes clinical programs for Duchenne muscular dystrophy (DMD) and Huntington's disease, as well as several preclinical programs utilizing its versatile RNA medicines platform.
Find out what a historical investment in WAVE LIFE SCIENCES LTD would be worth today using our WVE stock calculator.
Market Capitalisation
$627.19M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.66M
High today
$3.34
Low today
$3.12
Open price
$3.33
52-week high
$21.73
52-week low
$3.04
Ready to start your investing journey with Stake?
Open an accountThis is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in WVE on Stake
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
WVE related stocks